Search research articles
Contact Us
Filters
Showing results (441-450 of 768) with videos related to
Page
of 77
Sort By:
British Journal of Haematology
|
May 1, 1997
Allogeneic blood or marrow transplantation for chronic lymphocytic leukaemia: timing of transplantation and potential effect of fludarabine on acute graft-versus-host disease
I F Khouri, D Przepiorka, K van Besien, et al.
Blood
|
April 6, 2011
Impact of immune modulation with anti-T-cell antibodies on the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies
Robert J Soiffer, Jennifer Lerademacher, Vincent Ho, et al.
Blood
|
April 13, 2012
Reduced-intensity conditioning transplantation in acute leukemia: the effect of source of unrelated donor stem cells on outcomes
Claudio G Brunstein, Mary Eapen, Kwang Woo Ahn, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
December 4, 2017
Fractures frequently occur in older cancer patients: the MD Anderson Cancer Center experience
Beatrice J Edwards, Ming Sun, Xiaotao Zhang, et al.
Bone Marrow Transplantation
|
May 1, 1997
Management of lymphoma recurrence after allogeneic transplantation: the relevance of graft-versus-lymphoma effect
K W van Besien, M de Lima, S A Giralt, et al.
Cancer Research
|
September 3, 2015
Tuning Sensitivity of CAR to EGFR Density Limits Recognition of Normal Tissue While Maintaining Potent Antitumor Activity
Hillary G Caruso, Lenka V Hurton, Amer Najjar, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 3, 2010
Intravenous busulfan plus melphalan is a highly effective, well-tolerated preparative regimen for autologous stem cell transplantation in patients with advanced lymphoid malignancies
Partow Kebriaei, Timothy Madden, Reza Kazerooni, et al.
Cancer
|
March 22, 2017
Cytogenetics and comorbidity predict outcomes in older myelodysplastic syndrome patients after allogeneic stem cell transplantation using reduced intensity conditioning
Orhan Kemal Yucel, Rima M Saliba, Gabriella Rondon, et al.
Bone Marrow Transplantation
|
March 19, 2013
Adenoviral infections in adult allogeneic hematopoietic SCT recipients: a single center experience
M Yilmaz, R F Chemaly, X Y Han, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 21, 1998
Safeguarding the administration of high-dose chemotherapy: a national practice survey by the American Society for Blood and Marrow Transplantation
C S Chen, K Seidel, J O Armitage, et al.
Page
of 77
Search research articles
Search
Showing results (441-450 of 768) with videos related to
Sort By:
Page
of 77
British Journal of Haematology
|
May 1, 1997
Allogeneic blood or marrow transplantation for chronic lymphocytic leukaemia: timing of transplantation and potential effect of fludarabine on acute graft-versus-host disease
I F Khouri, D Przepiorka, K van Besien, et al.
Blood
|
April 6, 2011
Impact of immune modulation with anti-T-cell antibodies on the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies
Robert J Soiffer, Jennifer Lerademacher, Vincent Ho, et al.
Blood
|
April 13, 2012
Reduced-intensity conditioning transplantation in acute leukemia: the effect of source of unrelated donor stem cells on outcomes
Claudio G Brunstein, Mary Eapen, Kwang Woo Ahn, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
December 4, 2017
Fractures frequently occur in older cancer patients: the MD Anderson Cancer Center experience
Beatrice J Edwards, Ming Sun, Xiaotao Zhang, et al.
Bone Marrow Transplantation
|
May 1, 1997
Management of lymphoma recurrence after allogeneic transplantation: the relevance of graft-versus-lymphoma effect
K W van Besien, M de Lima, S A Giralt, et al.
Cancer Research
|
September 3, 2015
Tuning Sensitivity of CAR to EGFR Density Limits Recognition of Normal Tissue While Maintaining Potent Antitumor Activity
Hillary G Caruso, Lenka V Hurton, Amer Najjar, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 3, 2010
Intravenous busulfan plus melphalan is a highly effective, well-tolerated preparative regimen for autologous stem cell transplantation in patients with advanced lymphoid malignancies
Partow Kebriaei, Timothy Madden, Reza Kazerooni, et al.
Cancer
|
March 22, 2017
Cytogenetics and comorbidity predict outcomes in older myelodysplastic syndrome patients after allogeneic stem cell transplantation using reduced intensity conditioning
Orhan Kemal Yucel, Rima M Saliba, Gabriella Rondon, et al.
Bone Marrow Transplantation
|
March 19, 2013
Adenoviral infections in adult allogeneic hematopoietic SCT recipients: a single center experience
M Yilmaz, R F Chemaly, X Y Han, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 21, 1998
Safeguarding the administration of high-dose chemotherapy: a national practice survey by the American Society for Blood and Marrow Transplantation
C S Chen, K Seidel, J O Armitage, et al.
Page
of 77